Session information

[JSNP/JSCNP joint meeting] Symposia

JSNP/JSCNP joint meeting » Symposia

Symposium 14
Recent Advance in Research and Development of Novel Antidepressants

Sat. May 25, 2024 2:25 PM - 3:40 PM Room 12 (Hall D5)

Chair: Shigeyuki Chaki (Research Headquarters, Taisho Pharmaceutical Co., Ltd.), Haruhide Kimura (Neuroscience Drug Discovery Unit, Research,Takeda Pharmaceutical Co. Ltd.)

+Add all to schedule

[JSY14-1] Development of the novel antidepressant arketamine

*Kenji Hashimoto¹ (1. Chiba University Center for Forensic Mental Health)

[JSY14-2] Development of GABA_A receptor positive allosteric modulator S-812217 (zuranolone) and research of antidepressant action mechanism related with amygdala.

*Keiko Takasu¹, Yosuke Yawata¹, Ryoichi Tashima¹, Hiroyuki Aritomi², Shinji Shimada², Tomoko Motomiya¹, Koichi Ogawa¹ (1. Shionogi & Co., Ltd, 2. Shionogi TechnoAdvance Research)

[JSY14-3] Development of AMPA Receptor Potentiators for Treatment of Depression

*Hiroe Hara¹ (1. Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited)

[JSY14-4] Potential of Psychedelic-Inspired Drug Discovery for Next-Generation Antidepressants

*Hiroyuki Koike¹, Ichiro Horinokita¹, Reiko Yasufuku¹, Mikio Suzuki¹, Takeo Funakoshi¹, Takashi Futamura¹ (1. Department of CNS Research, Otsuka Pharmaceutical Co., Ltd.)

Authentication

Please log in with your participant account.
» Participant Log In

▲